Pierangeli et al showed the pathogenic potential of IgA in a murine model [179] and proposed the potential for IgA aβ2GPI positive patients to develop APS even in the absence of IgG and IgM aβ2GPI. The gene discussed is CD40LG; the disease is autoimmune polyendocrinopathy.